TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $827,003 | -38.8% | 1,251,139 | -27.4% | 0.08% | -23.1% |
Q1 2023 | $1,350,706 | -80.1% | 1,722,400 | -42.6% | 0.10% | -76.3% |
Q4 2022 | $6,779,469 | +108.9% | 2,999,765 | +86.2% | 0.44% | +109.0% |
Q3 2022 | $3,246,000 | -46.9% | 1,610,822 | -2.0% | 0.21% | -31.6% |
Q2 2022 | $6,114,000 | -29.7% | 1,643,438 | +23.2% | 0.31% | -20.3% |
Q1 2022 | $8,697,000 | -48.7% | 1,333,947 | -8.4% | 0.38% | -35.5% |
Q4 2021 | $16,964,000 | -27.1% | 1,456,147 | +16.6% | 0.60% | -18.6% |
Q3 2021 | $23,262,000 | +154.0% | 1,249,309 | +189.1% | 0.73% | +181.9% |
Q2 2021 | $9,160,000 | +1121.3% | 432,072 | +1069.2% | 0.26% | +1081.8% |
Q1 2021 | $750,000 | -64.0% | 36,956 | -53.0% | 0.02% | -66.2% |
Q4 2020 | $2,085,000 | +24.1% | 78,576 | +4.8% | 0.06% | +27.5% |
Q3 2020 | $1,680,000 | – | 75,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |